World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
110
Citations
40740
World Ranking
508
National Ranking
20

Medicine

D-Index
110
Citations
40742
World Ranking
5601
National Ranking
212

Gosse J. Adema publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Gosse J. Adema sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 341 publications — 72nd percentile

72% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Gosse J. Adema D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Gosse J. Adema sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 110 D-Index — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Gosse J. Adema is affiliated with Radboud University in the Netherlands. Their research spans multiple intersecting fields including Biochemistry, Genetics and Molecular Biology, Medicine, and Immunology and Microbiology. The scholar has a considerable publication record in Immunology and Molecular Biology, with significant contributions also to Oncology, Cancer Research, and Radiology, Nuclear Medicine and Imaging.

The research topics addressed by Adema focus on diverse aspects of cancer and immunology, including:

  • Cancer, Hypoxia, and Metabolism
  • Immunotherapy and Immune Responses
  • Cancer Immunotherapy and Biomarkers
  • Glycosylation and Glycoproteins Research
  • Immune cells in cancer
  • RNA modifications and cancer
  • Immune Response and Inflammation

Adema's recent selected publications highlight ongoing investigations into the tumor immune environment and immune signaling pathways:

  • "Sialoglycans and Siglecs Can Shape the Tumor Immune Microenvironment," 2020, Trends in Immunology
  • "Differential expansion of circulating human MDSC subsets in patients with cancer, infection and inflammation," 2020, Journal for ImmunoTherapy of Cancer
  • "Probing the binding specificities of human Siglecs by cell-based glycan arrays," 2021, Proceedings of the National Academy of Sciences
  • "Targeting Oxidative Phosphorylation to Increase the Efficacy of Radio- and Immune-Combination Therapy," 2021, Clinical Cancer Research
  • "Siglec Signaling in the Tumor Microenvironment," 2021, Frontiers in Immunology

The scientist frequently publishes in specialized venues, notably:

  • Radiotherapy and Oncology
  • Frontiers in Immunology
  • Journal for ImmunoTherapy of Cancer
  • Cellular and Molecular Life Sciences
  • Clinical Cancer Research

Regular collaborators who have co-authored multiple papers with Adema include Johan Bussink, Paul N. Span, Marleen Ansems, Sandra Heskamp, and Lenneke A. M. Cornelissen. These collaborations reflect a concentrated network in the domains of oncology and immunology research.

Best Publications

  • Identification of DC-SIGN, a Novel Dendritic Cell–Specific ICAM-3 Receptor that Supports Primary Immune Responses

    T.B.H. Geijtenbeek;R. Torensma;S.J. van Vliet;G.C.F. van Duijnhoven

  • C-type lectin receptors on dendritic cells and langerhans cells

    Carl G Figdor;Yvette van Kooyk;Gosse J Adema

  • The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells

    Dennis S. U. Lindau;Paul R. Gielen;Michiel Kroesen;Pieter Wesseling;Pieter Wesseling

  • Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy

    I Jolanda M de Vries;W Joost Lesterhuis;Jelle O Barentsz;Pauline Verdijk

  • Toll-like receptor 2 controls expansion and function of regulatory T cells.

    Roger P.M. Sutmuller;Martijn H.M.G.M. den Brok;Matthijs Kramer;Erik J. Bennink

  • Human Dectin-1 Deficiency and Mucocutaneous Fungal Infections

    Bart Ferwerda;Gerben Ferwerda;Theo S. Plantinga;Janet A. Willment

  • Toll-Like Receptor 2 Suppresses Immunity against Candida albicans through Induction of IL-10 and Regulatory T Cells

    Mihai G. Netea;Roger Sutmuller;Corinna Hermann;Chantal A. A. Van der Graaf

  • Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes

    A.B.H. Bakker;M.W.J. Schreurs;A.J. de Boer;Y. Kawakami

  • Different faces of the heme-heme oxygenase system in inflammation

    Frank A. D. T. G. Wagener;Hans-Dieter Volk;Dean Willis;Nader G. Abraham

  • A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells

    G.J. Adema;F.C. Hartgers;R.G.G. Verstraten;E. de Vries

  • Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state

    I. Jolanda M. de Vries;Daniëlle J. E. B. Krooshoop;Nicole M. Scharenborg;W. Joost Lesterhuis

  • LAIR-1, a Novel Inhibitory Receptor Expressed on Human Mononuclear Leukocytes

    Linde Meyaard;Gosse J Adema;Chiwen Chang;Erica Woollatt

  • In Situ Tumor Ablation Creates an Antigen Source for the Generation of Antitumor Immunity

    Martijn H. M. G. M. den Brok;Roger P. M. Sutmuller;Robbert van der Voort;Erik J. Bennink

  • Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase.

    Frank A. D. T. G. Wagener;Andreas Eggert;Otto C. Boerman;Wim J. G. Oyen

  • Sialic Acids Sweeten a Tumor's Life

    Christian Büll;Marieke A. Stoel;Martijn H. den Brok;Gosse J. Adema

  • The C-type lectin DC-SIGN (CD209) is an antigen-uptake receptor for Candida albicans on dendritic cells.

    Alessandra Cambi;Karlijn Gijzen;I. Jolanda M. de Vries;Ruurd Torensma

  • NOD2 and toll-like receptors are nonredundant recognition systems of Mycobacterium tuberculosis.

    Gerben Ferwerda;Stephen E. Girardin;Bart Jan Kullberg;Lionel Le Bourhis

  • Syk kinase is required for collaborative cytokine production induced through Dectin-1 and Toll-like receptors.

    Kevin M. Dennehy;Gerben Ferwerda;Inês Faro-Trindade;Elwira Pyz

  • Dectin-1 synergizes with TLR2 and TLR4 for cytokine production in human primary monocytes and macrophages.

    Gerben Ferwerda;Friederike Meyer-Wentrup;Bart-Jan Kullberg;Mihai G. Netea

  • Maturation of Dendritic Cells Is a Prerequisite for Inducing Immune Responses in Advanced Melanoma Patients

    I. Jolanda M. de Vries;W. Joost Lesterhuis;Nicole M. Scharenborg;Linda P. H. Engelen

Frequent Co-Authors

Carl G. Figdor
Carl G. Figdor Radboud University
I. Jolanda M. de Vries
I. Jolanda M. de Vries Radboud University
Cornelis J. A. Punt
Cornelis J. A. Punt University of Amsterdam
Mihai G. Netea
Mihai G. Netea Radboud University
Pieter Wesseling
Pieter Wesseling University of Amsterdam
Gerty Schreibelt
Gerty Schreibelt Radboud University
Ruurd Torensma
Ruurd Torensma Radboud University
Stefan Nierkens
Stefan Nierkens University Medical Center Utrecht
Bart Jan Kullberg
Bart Jan Kullberg Radboud University
Frank J. M. van Kuppeveld
Frank J. M. van Kuppeveld Utrecht University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those studying Immunology, pursuing related online degrees can open diverse career opportunities, particularly in healthcare. Many professionals consider transitioning into advanced nursing roles that complement immunology expertise. For example, registered nurses aiming to specialize can explore accelerated nurse practitioner programs, which offer a fast track to nurse practitioner credentials.

Nurses interested in expanding their practice areas may look into obtaining an fnp to acute care certification, allowing for critical care specialization that often intersects with immunology-related patient care. This transition can enhance clinical skills and job prospects.

For individuals without a nursing background, enrolling in 12-month accelerated nursing programs online for non nurses offers an efficient pathway into the field, creating new opportunities for those passionate about immunology and healthcare.

Understanding the financial outlook is also crucial, and resources like how much do dnp nurses make provide valuable insights into salary expectations across states, aiding in informed career planning.

Best Scientists Citing Gosse J. Adema

Trending Scientists

Recently Published Articles